Related Experiment Video
Updated: Jun 11, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomy
Edoardo Beatrici1,2,3, Mario de Angelis1,2,4, Ricardo Almeida-Magana5
1ORSI Academy, Melle, Belgium.
BJU International
|June 10, 2026
Summary
Ex vivo fluorescence confocal microscopy (FCM) offers a real-time tool to detect positive surgical margins during robot-assisted radical prostatectomy (RARP). This consensus defines expert recommendations for its safe clinical integration and future research.
Area of Science:
- Uro-oncology
- Surgical pathology
- Medical imaging
Background:
- Positive surgical margins (PSMs) in robot-assisted radical prostatectomy (RARP) are linked to increased prostate cancer recurrence and the need for further treatment.
- Intraoperative frozen section is not routinely feasible for PSM detection.
- Ex vivo fluorescence confocal microscopy (FCM) presents a promising, rapid alternative, but its clinical application requires standardization and further evidence.
Purpose of the Study:
- To establish international expert consensus on the clinical application, workflow, and research priorities for ex vivo fluorescence confocal microscopy (FCM) during RARP.
- To provide a framework for the safe integration of FCM into RARP procedures.
Main Methods:
- A modified Delphi process, adhering to the RAND/UCLA Appropriateness Method and ACCORD checklist, was employed.
- Thirty-two international urology and pathology experts participated in a hybrid consensus meeting following literature review and online sessions.
- Forty-four evidence-based items were anonymously voted on to achieve consensus (≥80% agreement).
Main Results:
- Consensus was reached on 24 of 44 items (55%). Key agreements include risk-adapted FCM use (97%), its role as an adjunct for nerve-sparing decisions (87%), preference for en-face imaging (82%), and a 30-minute reporting time (85%).
- Endorsement of formal certification for image interpretation (83%), standardized reporting of positive margin length (82%), and feasibility of remote reporting (84%).
- Large PSMs (>3 mm) in high-risk cases necessitate complete neurovascular bundle resection (96%).
Conclusions:
- This Delphi consensus establishes a structured framework for intraoperative FCM use in RARP, outlining indications, workflow standards, and training needs.
- Further multicenter studies are crucial to evaluate the oncological and functional outcomes of FCM and to develop standardized implementation pathways.
